€2.8 Million Hemophilia Treatment: A Breakthrough or Price Gouging?
Hemgenix Offers New Hope for Hemophilia B Patients in Europe A new gene therapy treatment, Hemgenix, is providing “improved management” for adults wiht hemophilia B, a hereditary bleeding disorder. The CHU de Nantes in France is one of the first centers in Europe to deploy this innovative therapy, which has recently gained marketing authorization in … Read more